With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
After a heart attack, this peptide protects the heart from further injury
Featured Event
ECHO PITCH 2024
Virtual Library
Visit our YouTube channel filled with world-class heart failure educational sessions on diverse topics
Investigating Heart Failure
Personalized Medicine
Equitable Access to Care
Translating Innovation
For Patients
For Clinicians
For Researchers
New study explores how Apple Watch can help identify worsening heart failure early
Ted Rogers Centre scientific lead and renowned cardiologist Dr. Heather Ross has launched a new clinical study, in collaboration with Apple to test if remote monitoring with Apple Watch can help with early identification of worsening heart failure.
In this study, data collected using an Apple Watch will be compared to data routinely collected from the rigorous physical tests that patients normally undergo, to see if Apple Watch health sensors and features, including the Blood Oxygen app and mobility metrics, can provide early warning for worsening heart failure.
Suitable patients from the heart function program at the Peter Munk Cardiac Centre, will be asked to participate in the three month active monitoring study, with each patient using an iPhone and Apple Watch Series 6, and a two-year follow up. The study will investigate the ability of patients to perform traditionally clinic-based assessments in the comfort of their own home. All participant data collected during the study will be stored in an encrypted form, and participants have the ability to opt-out at any time.
“We think that biometric data derived from Apple Watch may provide comparable, precise, and accurate measurements of fitness, prognostic markers and early warning signals, compared to traditional diagnostics,” says Dr. Heather Ross, Division Head of Cardiology, at UHN’s Peter Munk Cardiac Centre.
Goal: high-quality care for everyone, anywhere
Combining this new technology with expertise in biomedical science, and leveraging the existing Digital Cardiovascular Health Platform for 8,000 heart failure patients already followed by UHN, should give patients and clinicians an exciting new opportunity to gain more precise, in the moment assessments of heart health.
“Surfacing heart health insights has played a key role in the evolution of Apple Watch and we’re continually humbled by the responses we hear from users on the impact it has had on their lives,” says Dr. Sumbul Desai, Apple’s vice-president of Health. “We’re thrilled to be collaborating with UHN and Dr. Heather Ross to better understand how the powerful sensors in Apple Watch can potentially help patients better manage heart failure, from the comfort of their own home.”
It was in Tanzania, on top of Mount Kilimanjaro, that Dr. Ross first glimpsed the future of healthcare. A routine phone call led to her “aha” moment. If she could use her phone from a mountaintop, why couldn’t this technology be used to reach patients who can not always travel to receive quality care? Later experiences with text messaging in Uganda, combined with the experience of traveling the Nahanni River into remote Canadian First Nations communities, further reinforced Dr. Ross’ determination to use technology to solve issues of equity in healthcare.
“My goal is to make high quality care, accessible to everyone, no matter where they are,” says Dr. Ross. “If we can use wearable technology to accurately monitor for essential diagnostics, we can reach all kinds of people, including vulnerable communities who traditionally have been challenged by issues of remote geography or homelessness.”